Purchases and Sales Made in Q4 2023 in Heron Therapeutics, Inc. (HRTX)
This table provides information about the institutional ownership of Heron Therapeutics, Inc. (HRTX) during Q4 2023. The information is specifically focused on institutions that hold shares of HERON THERAPEUTICS, INC. .
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Weiss Multi Strategy Advisers LLC
New York, NY |
SELL
|
- |
-38.6K- 29.99% |
$20.8K - $70.2K
|
90K
$153K
|
|
|
Feb 14, 2024
Q4 2023
|
Clearline Capital LP
New York, NY |
SELL
|
- |
-81.3K- 1.32% |
$43.9K - $148K
|
6.07M
$10.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-85.9K- 69.98% |
$46.4K - $156K
|
36.9K
$62.7K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-115K- 62.35% |
$61.9K - $209K
|
69.2K
$118K
|
|
|
Feb 09, 2024
Q4 2023
|
Jw Asset Management, LLC
Armonk, NY |
SELL
|
- |
-115K- 4.78% |
$62.1K - $209K
|
2.29M
$3.9M
|
|
|
Feb 12, 2024
Q4 2023
|
Cm Management, LLC
|
SELL
|
- |
-125K- 27.78% |
$67.5K - $228K
|
325K
$553K
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-131K- 63.42% |
$70.8K - $239K
|
75.6K
$129K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-306K- 39.81% |
$165K - $556K
|
462K
$786K
|
|
|
Feb 14, 2024
Q4 2023
|
Palisade Capital Management LLC
Fort Lee, NJ |
SELL
|
- |
-465K- 11.31% |
$251K - $846K
|
3.65M
$6.2M
|
|
|
Feb 09, 2024
Q4 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-553K- 7.95% |
$299K - $1.01M
|
6.4M
$10.9M
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-964K- 11.87% |
$521K - $1.76M
|
7.16M
$12.2M
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-6.73M- 98.89% |
$3.64M - $12.3M
|
75.6K
$129K
|